Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2001
11/01/2001WO2001080847A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
11/01/2001WO2001080828A2 Improved water-insoluble drug particle process
11/01/2001WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001035986A3 Methods and compositions for modulating er-stress-induced cholesterol accumulation
11/01/2001WO2001032866A3 Hybrid adaptor receptors
11/01/2001WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001WO2001018161A3 Process for the preparation of conjugated linoleic acid (cla)
11/01/2001WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001WO2001012233A3 Sustained release formulation of a peptide
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001WO2000043036A3 Lipoprotein complexes and compositions containing them
11/01/2001US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001US20010036957 Diabetic neuropathy, nephropathy, ophthalimopathy, arteriosclerosis
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001US20010036937 Intensive care unit
11/01/2001US20010036916 Insoluble insulin compositions
11/01/2001US20010036500 For enriching foods or beverages, anemia treatment
11/01/2001US20010036479 Having preferred particle size distribution characteristics; antidiabetic agent
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407083A1 Apo-ai/aii peptide derivatives
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001CA2406659A1 Transparent liquid composition
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406067A1 Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
11/01/2001CA2405992A1 A combination of pinitol and creatine to enhance uptake and retention of creatine
11/01/2001CA2405559A1 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149085A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149079A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP1148874A1 Use of anticonvulsant derivatives for treating bulimia nervosa
10/31/2001EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/31/2001EP1148871A1 Core tablet for controlled release of gliclazide after oral administration
10/31/2001EP1148793A1 Method of preparing microparticles of phytosterols or phytostanols
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0613376B1 Use of igf-1
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320120A Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments
10/31/2001CN1319396A Medicinal composition
10/31/2001CN1319394A Easy effervescent, moistureproof antiseptic antiphlogistic tablet and preparation process thereof
10/31/2001CN1319393A Application of chrysophanic acid in curing hyperlipemia
10/31/2001CN1319343A Health care food having functions of reducing weight and preventing cardiovascular disease
10/31/2001CN1073814C Bitersguash extract sugar-reducing milk power and its preparation process
10/30/2001US6310101 Administering to the mammal suffering from panic disorder an effective amount of a venlafaxine derivative
10/30/2001US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001US6310057 α-ketoamide multicatalytic protease inhibitors
10/30/2001US6309878 Glucose-inducible recombinant viral vector
10/30/2001US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309645 A method of suppressing an immune response in a mammal.
10/30/2001CA2052375C Parathyroid hormone derivatives
10/28/2001CA2345569A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/27/2001CA2345180A1 Methods of treating obesity using a neurotensin receptor ligand
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079453A1 Cell culture method, cell cluster obtained by said methods and use thereof
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079206A1 Tricyclic quinazolinediones
10/25/2001WO2001079202A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 1298